Questions EMERGE as Biogen claims aducanumab turnaround-Reference-Cited by-同舟云学术

Questions EMERGE as Biogen claims aducanumab turnaround

Published:2019-11-29 Issue:2 Volume:16 Page:63-64
ISSN:1759-4758
Container-title:Nature Reviews Neurology
language:en
Short-container-title:Nat Rev Neurol

Author:

Howard Robert,Liu Kathy Y.

Publisher

Springer Science and Business Media LLC

Subject

Cellular and Molecular Neuroscience,Neurology (clinical)

Link

http://www.nature.com/articles/s41582-019-0295-9.pdf

Reference9 articles.

1. Sevigny, J. et al. The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease. Nature 537, 50–56 (2016).

2. Biogen and Eisai to Discontinue Phase 3 ENGAGE and EMERGE Trials of aducanumab in Alzheimer’s disease. investors.biogen.com http://investors.biogen.com/news-releases/news-release-details/biogen-and-eisai-discontinue-phase-3-engage-and-emerge-trials (2019).

3. Biogen. Biogen Q1 2019 Earnings Presentation. investors.bogen.com http://investors.biogen.com/static-files/1e8f9954-58d4-41cf-a6d7-6626338656c3 (2019).

4. Biogen. Biogen Q3 2019 Earnings Presentation. investors.biogen.com http://investors.biogen.com/static-files/40565136-b61f-4473-9e58-9be769bbac6c (2019).

5. Siemers, E. R. et al. Phase 3 solanezumab trials: secondary outcomes in mild Alzheimer’s disease patients. Alzheimers Dement. 12, 110–120 (2016).

Cited by 102 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stimulating myelin restoration with BDNF: a promising therapeutic approach for Alzheimer's disease;Frontiers in Cellular Neuroscience;2024-09-02

2. Promising Strategies to Reduce the SARS-CoV-2 Amyloid Deposition in the Brain and Prevent COVID-19-Exacerbated Dementia and Alzheimer’s Disease;Pharmaceuticals;2024-06-16

3. Unraveling Alzheimer’s: the promise of aducanumab, lecanemab, and donanemab;The Egyptian Journal of Neurology, Psychiatry and Neurosurgery;2024-06-14

4. Early- and Late-Onset Alzheimer’s Disease: Two Sides of the Same Coin?;Diseases;2024-05-22

5. A positive feedback inhibition of isocitrate dehydrogenase 3β on paired-box gene 6 promotes Alzheimer-like pathology;Signal Transduction and Targeted Therapy;2024-04-29